| 17545544 |
Sorafenib inhibits imatinib-resistant KIT and platelet-derived growth factor receptor beta gatekeeper mutants
Guida, T,
Anaganti, S,
Provitera, L,
Gedrich, R,
Sullivan, E,
Wilhelm, SM,
Santoro, M,
Carlomagno, F
|
Clin. Cancer Res. |
2007 |
| 22665524 |
Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumors
Heinrich, MC,
Mariño-Enríquez, A,
Presnell, A,
Donsky, RS,
Griffith, DJ,
McKinley, A,
Patterson, J,
Taguchi, T,
Liang, CW,
Fletcher, JA
|
Mol. Cancer Ther. |
2012 |
| 30792533 |
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
Serrano, C,
Mariño-Enríquez, A,
Tao, DL,
Ketzer, J,
Eilers, G,
Zhu, M,
Yu, C,
Mannan, AM,
Rubin, BP,
Demetri, GD,
Raut, CP,
Presnell, A,
McKinley, A,
Heinrich, MC,
Czaplinski, JT,
Sicinska, E,
Bauer, S,
George, S,
Fletcher, JA
|
Br. J. Cancer |
2019 |